Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding DomainHuan Ma, Tengchuan Jin, Peigen Zhou et al.|Journal of Virology|2021Cited by 80
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including OmicronHuan Ma, Tengchuan Jin, Xinghai Zhang et al.|Cell Research|2022Cited by 41
A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administrationHuan Ma, Sandra Chiu, Xinghai Zhang et al.|Cell Discovery|2022Cited by 37
Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital dischargeHuan Ma, Tengchuan Jin, Dan Zhao et al.|Science China Life Sciences|2020Cited by 30
An engineered bispecific nanobody in tetrameric secretory IgA format confers broad neutralization against SARS-CoV-1&2 and most variantsWeihong Zeng, Tengchuan Jin, Xiaoying Jia et al.|International Journal of Biological Macromolecules|2023Cited by 12